For citations:
Gafanov R.A., Dzidzaria A.G., Rebrikova V.A. Experience of using atezolizumab in 1st line therapy of metastatic urothelial cancer. Cancer Urology. 2019;15(3):113-119. (In Russ.) https://doi.org/10.17650/1726-9776-2019-15-3-113-119
Gafanov R.A., Dzidzaria A.G., Rebrikova V.A. Experience of using atezolizumab in 1st line therapy of metastatic urothelial cancer. Cancer Urology. 2019;15(3):113-119. (In Russ.) https://doi.org/10.17650/1726-9776-2019-15-3-113-119